In addition, preclinical studies on the PFC of schizophrenia animal models have reported decreased levels of DARPP-32 [494], whereas post-mortem clinical studies on the superior temporal gyrus and DLPFC of schizophrenia patients have found a reduced expression [495,496]. Here, PPP1R1B is linked to schizophrenia.